Brief: Armata And Innoviva Will Invest $25 Mln For Armata's Bacteriophage Development Programs

Innoviva

28/01/2020 12:30

Jan 28 (Reuters) - Armata Pharmaceuticals Inc  ARMP.A :
    * ARMATA PHARMACEUTICALS AND INNOVIVA ANNOUNCE $25 MILLION
STRATEGIC INVESTMENT TO SUPPORT ADVANCEMENT OF ARMATA'S
BACTERIOPHAGE DEVELOPMENT PROGRAMS
    * ARMATA PHARMACEUTICALS INC - INNOVIVA WILL PURCHASE
APPROXIMATELY 8.7 MILLION NEWLY ISSUED SHARES OF ARMATA'S COMMON
STOCK, AT A PRICE OF $2.87 PER SHARE
    * ARMATA PHARMACEUTICALS INC - STOCK PURCHASES ARE EXPECTED
TO
OCCUR IN TWO TRANCHES

Source text for Eikon:  ID:nPn7PFDHSa 
Further company coverage:  ARMP.A 

 ((Reuters.Briefs@thomsonreuters.com;))